NexImmune CFO Timothy Stover resigns; Albert Marchio named interim CFO

NexImmune, Inc.

Timothy Stover, principal financial and accounting officer, resigns effective April 16, 2024; not due to disagreement.
Albert N. Marchio II appointed Interim CFO and principal financial/accounting officer, effective upon Stover's resignation.
Marchio, 71, has 32 years pharma industry experience; currently a consultant via Danforth Advisors LLC.
Danforth Advisors will provide interim CFO services under a consulting agreement with hourly rate and indemnification terms.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Albert N. Marchio II

Interim Chief Financial Officer

NexImmune, Inc.

Effective: 2024-04-16
Filed: April 5, 2024, 7:59 PM ET

On April 5, 2024, the Board of Directors of the Company appointed Albert N. Marchio II as Interim Chief Financial Officer and designated him to serve as the principal financial officer and principal accounting officer of the Company effective upon Mr. Stover’s resignation (the “Transition Date”).

Departed

Timothy Stover

Vice President, Corporate Controller and principal financial officer and principal accounting officer

NexImmune, Inc.

Effective: 2024-04-16
Successor: Albert N. Marchio II
Filed: April 5, 2024, 7:59 PM ET

On April 1, 2024, Timothy Stover, Vice President, Corporate Controller and the principal financial officer and principal accounting officer of NexImmune, Inc. (the “Company”), notified the Company of his intention to resign from all positions he holds at the Company, effective on April 16, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Albert N. Marchio II was appointed as Interim Chief Financial Officer at NexImmune, Inc..

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

On April 5, 2024, the Board of Directors of the Company appointed Albert N. Marchio II as Interim Chief Financial Officer and designated him to serve as the principal financial officer and principal accounting officer of the Company effective upon Mr. Stover’s resignation (the “Transition Date”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Timothy Stover resigned as Vice President, Corporate Controller and principal financial officer and principal accounting officer at NexImmune, Inc..

Action: resigned
Role: Vice President, Corporate Controller and principal financial officer and principal accounting officer

Exact text from the filing

On April 1, 2024, Timothy Stover, Vice President, Corporate Controller and the principal financial officer and principal accounting officer of NexImmune, Inc. (the “Company”), notified the Company of his intention to resign from all positions he holds at the Company, effective on April 16, 2024.

View on SEC.gov

Source: SEC EDGAR

accession 0001193125-24-088454

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.